Table 2.
Dun Test | |||
---|---|---|---|
Clinicopathological features | Tumour |
Tumour/ Healthy |
Net increase |
Age (years) <69 vs > 77 |
n.s. | n.s. | 7.78 |
Histologic type: Moderately differentiated vs Well differentiated |
2.53 | 6.59 | 8.24 |
T (T1/T2 vs T3) | 4.0 | n.s. | 1.9 |
T (T1/T2 vs T4) | 11 | 3.6 | 5.0 |
N (N0 vs N2) | 7.0 | 3.0 | 5.6 |
AJCC (I vs IIIb) | 6.0 | 2.8 | 4.9 |
AJCC (I vs IIIc) | 5.8 | 2.6 | 4.5 |
AJCC (IIa vs IIIb) | 7.0 | 5.2 | 6.4 |
AJCC (IIa vs IIIc) | 6.9 | 4.8 | 5.9 |
AJCC (IIa vs IV) | 4.4 | n.s. | n.s. |
AJCC (IIb vs IIIb) | 5.4 | 1.8 | 3.6 |
AJCC (IIb vs IIIc) | 5.3 | 1.6 | 3.3 |
AJCC (IIb vs IV) | 3.5 | n.s. | n.s. |
T (T1/T2 vs T3) | 4.0 | n.s. | 1.9 |
Comparisons of ST6Gal I activity between clinicopathological features by Dun test. The data represent the value of Dun test, which are indicative of the degree of correlation between the variables. Tumour/Healthy: quotient of the enzyme activity from the two tissues of the same patient. Net increase: difference of the enzyme activity from tumour and healthy tissues from the same patient. n.s.: not significant.